Thursday, May 2, 2013
This week in therapeutics
Publication and contact
Mouse studies suggest
radionuclide-labeled Listeria monocytogenes could help treat
metastatic pancreatic cancer. In a mouse model for metastatic pancreatic
cancer, an attenuated strain of L. monocytogenes showed greater
infection and replication in metastatic lesions than in primary tumors and
normal tissues. In the mouse model, attenuated L. monocytogenes linked
to rhenium-188 (188Re) decreased the number and size of metastatic
lesions compared with the bacterium or 188Re alone. Next steps
include testing the 188Re-labeled L. monocytogenes in
xenograft models for pancreatic cancer.
Advaxis Inc.'s Lovaxin C (ADXS11-001),
L. monocytogenes-based immunotherapy expressing HPV type 16 E7, is in
Phase II testing to treat cervical cancer and Phase I/II testing to treat
colorectal and head and neck cancers.
Aduro BioTech Inc.'s CRS-207 (ANZ-207),
a live, attenuated strain of L. monocytogenes that expresses human mesothelin,
is in Phase II testing to treat pancreatic cancer and Phase I testing to
treat mesothelioma. (See Add radioactivity to the Listeria, page 6).
Published online May 2, 2013
Patented by the Albert
Einstein College of Medicine of Yeshiva University;
available for licensing
Quispe-Tintaya, W. et
Proc. Natl. Acad. Sci. USA;
published online April 22, 2013;
Contact: Claudia Gravekamp,
Albert Einstein College of Medicine of Yeshiva University, Bronx, N.Y.
Contact: Ekaterina Dadachova,
same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]